British journal of surgery · 2010 · 21 citations · 24 references
MedicineOncologyRadiation OncologyGastrointestinal Radiation OncologyRadiation BiophysicsRadiobiologyBiological Effects Of RadiationCellular Radiation ResponseRadiation BiologyRadiation TherapyRadiation ToxicityTissue Responses To RadiationEpithelial Barrier DamageInflammatory ChemokinesInflammatory Response To RadiationInflammatory Responses To RadiationIntestinal Barrier PermeabilityRadiation Effects On The Gastrointestinal TractRadiation-induced Endothelial DysfunctionRadiation-induced Inflammation
BACKGROUND: Radiotherapy is important in the management of pelvic malignancies, but radiation-induced intestinal damage is a dose-limiting factor. Microvascular injury and epithelial barrier dysfunction are considered to be rate-limiting aspects in radiation-induced enteropathy. This study investigated the role of Rho kinase signalling in radiation-induced inflammation and intestinal barrier dysfunction. METHODS: The specific Rho kinase inhibitor Y-27632 (1 and 10 mg/kg) was given to C57BL/6J mice before challenge with 20 Gy radiation. Leucocyte- and platelet-endothelium interactions in the colonic microcirculation were assessed by intravital microscopy. Levels of myeloperoxidase (MPO) and CXC chemokines (macrophage inflammatory protein 2 and cytokine-induced neutrophil chemoattractant), and intestinal leakage were quantified after 16 h. RESULTS: Radiation increased leucocyte and platelet recruitment, MPO activity, CXC chemokine production and intestinal leakage. Y-27632 significantly reduced radiation-induced leucocyte rolling and abolished adhesion; it also decreased platelet rolling and adhesion by 55 and 74 per cent respectively (P < 0·050). Inhibition of Rho kinase signalling significantly decreased radiation-provoked formation of CXC chemokines, MPO activity by 52 per cent, and intestinal leakage by 67 per cent (P < 0·050). CONCLUSION: Rho kinase activity constitutes an important signalling mechanism in radiation-induced inflammation and intestinal barrier dysfunction.
24
Rho GTPases and the control of cell behaviour
A Hall · Biochemical Society Transactions · 2005 · 567 citations